Andreas A. Kammerlander
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
Prognostic Thresholds of Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy.
Journal: JAMA cardiology
Published: August 31, 2026
Machine Learning-Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy.
Journal: JAMA cardiology
Published: August 28, 2026
Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes.
Journal: European journal of clinical investigation
Published: April 18, 2026
Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 24, 2026
Renal cortical T1 times at 1.5 T: exploratory reference estimates from a real-world cohort with preserved renal function.
Journal: European journal of radiology open
Published: February 02, 2026
Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.
Journal: Journal of clinical medicine
Published: January 26, 2026
The Neutrophil-Lymphocyte Ratio Is Associated with Cardiac Magnetic Resonance Imaging-Derived Myocardial Fibrosis.
Journal: Journal of clinical medicine
Published: January 14, 2026
Correction to: Total-body 11C-PIB PET/CT imaging of systemic amyloidosis: interorgan connectivity in cardiac amyloidosis for prognostic insights.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 05, 2026
CMR-derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis.
Journal: European journal of clinical investigation
Published: December 22, 2025
Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathy.
Journal: European journal of heart failure
Published: December 01, 2025
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.
Journal: Nature communications
Published: November 20, 2025
Last Updated: 09/26/2026